If you work with third-party vendors, such as medical education or meeting planning companies, you have to heighten — not relax — your vigilance about compliance with the new regulations, said panelists at the National Pharma Congress Audioconference held in September. The conference addressed steps pharmaceutical firms can take to comply with the Office of Inspector General's pharmaceutical guidance and avoid violating federal fraud, abuse, and anti-kickback laws.
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments